Si J - Search Results

1

Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study.

Huang Z, Li S, Yang X, Lu F, Huang M, Zhang S, Xiong Y, Zhang P, Si J, Ma Y, Yang Y. Huang Z, et al. Among authors: si j. Cancer Manag Res. 2019 Feb 8;11:1299-1308. doi: 10.2147/CMAR.S195355. eCollection 2019. Cancer Manag Res. 2019. PMID: 30799956 Free PMC article.

2

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.

Si J, Zhang P, Tian D, Wang X, Ma Y, Zhang J, Wang L, Yang Y. Si J, et al. World J Surg Oncol. 2017 Jan 28;15(1):34. doi: 10.1186/s12957-016-1094-z. World J Surg Oncol. 2017. PMID: 28129775 Free PMC article.

3

Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.

Zhang P, Kang B, Xie G, Li S, Gu Y, Shen Y, Zhao X, Ma Y, Li F, Si J, Wang J, Chen J, Yang H, Xu X, Yang Y. Zhang P, et al. Among authors: si j. Cancer Lett. 2019 Feb 1;442:53-67. doi: 10.1016/j.canlet.2018.10.035. Epub 2018 Oct 27. Cancer Lett. 2019. PMID: 30391781 Free article.

4

Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.

Huang Z, Ma Y, Zhang P, Si J, Xiong Y, Yang Y. Huang Z, et al. Among authors: si j. Anticancer Drugs. 2020 Jan;31(1):44-54. doi: 10.1097/CAD.0000000000000831. Anticancer Drugs. 2020. PMID: 31503013

5

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.

Si J, Ma Y, Bi JW, Xiong Y, Lv C, Li S, Wu N, Yang Y. Si J, et al. J Exp Clin Cancer Res. 2019 Dec 4;38(1):481. doi: 10.1186/s13046-019-1486-3. J Exp Clin Cancer Res. 2019. PMID: 31801598 Free PMC article.

6

Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.

Dai C, Liu B, Li S, Hong Y, Si J, Xiong Y, Wu N, Ma Y. Dai C, et al. Among authors: si j. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211056809. doi: 10.1177/15330338211056809. Technol Cancer Res Treat. 2021. PMID: 34825849 Free PMC article.

7

circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis.

Hong Y, Si J, Xiao B, Xiong Y, Dai C, Yang Y, Li S, Ma Y. Hong Y, et al. Among authors: si j. J Cancer. 2022 Feb 28;13(5):1540-1552. doi: 10.7150/jca.60124. eCollection 2022. J Cancer. 2022. PMID: 35371319 Free PMC article.

8

Hsa_circ_0007312 Promotes Third-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance through Pyroptosis and Apoptosis via the MiR-764/MAPK1 Axis in Lung Adenocarcinoma Cells.

Dai C, Ma Z, Si J, An G, Zhang W, Li S, Ma Y. Dai C, et al. Among authors: si j. J Cancer. 2022 Jun 27;13(9):2798-2809. doi: 10.7150/jca.72066. eCollection 2022. J Cancer. 2022. PMID: 35812182 Free PMC article.

9

Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.

Ma Y, Li M, Si J, Xiong Y, Lu F, Zhang J, Zhang L, Zhang P, Yang Y. Ma Y, et al. Among authors: si j. Int J Oncol. 2016 Jun;48(6):2349-58. doi: 10.3892/ijo.2016.3464. Epub 2016 Mar 30. Int J Oncol. 2016. PMID: 27035162

10

Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients.

Ma Y, Zhang P, An G, Zhang X, Zhang L, Si J, Zhang J, Yang Y. Ma Y, et al. Among authors: si j. Med Sci Monit. 2016 Oct 27;22:4017-4025. doi: 10.12659/msm.900661. Med Sci Monit. 2016. PMID: 27784882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,747 results

Search Page

Filters